Key points are not available for this paper at this time.
Introduction: Tools to screen orders submitted to companies synthesizing nucleic acids or machines that can synthesize them are vital to help ensure the building blocks for pathogens, toxins, or other biotechnology that could cause harm are kept in the right hands.
Piers Millett (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: